Interpreting TRIPS : globalisation of intellectual property rights and access to medicines / Hiroko Yamane.
2011
K1401.A4 1994 Y36 2011 (Map It)
Available at Cellar
Formats
Format | |
---|---|
BibTeX | |
MARCXML | |
TextMARC | |
MARC | |
DublinCore | |
EndNote | |
NLM | |
RefWorks | |
RIS |
Items
Details
Author
Title
Interpreting TRIPS : globalisation of intellectual property rights and access to medicines / Hiroko Yamane.
Published
Oxford ; Portland, Or. : Hart Pub., 2011.
Call Number
K1401.A4 1994 Y36 2011
ISBN
9781841139531 (hbk.)
184113953X (hbk.)
184113953X (hbk.)
Description
xlvi, 535 pages ; 25 cm
System Control No.
(OCoLC)607975204
Summary
For WTO members, the Trade-Related Aspects of Intellectual Property (TRIPS) Agreement outlines the minimum standards for Intellectual Property Rights (IPRs) protection and offers a global regime for IPR protection. However, the social costs of this regime often outweigh the benefits of IPR protection, particularly in the poorest countries where resources for research and development are inadequate. Today, after more than a decade of intense debate over global IPR protection, the problems remain acute despite limited evidence of co-operation and partnership, most notably in areas such as patent pooling and pricing in respect to AIDS drugs. This book examines the role of IPRs as incentives for innovation against the backdrop of the development and transfer of technology between globalized, knowledge-based, high-technology economies. The book retraces the origins, content, and interpretations of the TRIPS Agreement. It analyzes sources of controversy over IPRs, examining pharmaceutical industry strategies of emerging countries with different IPR policies. The book also draws attention to the fact that TRIPS is only an agreement about principles. Both the TRIPS rules and international customary rules of interpretation are flexible and a great deal depends on domestic policy objectives and their implementation. The author concludes that - for governments in developing countries, as well as for their business and scientific communities - IPR protection should be supporting domestic policies for innovation and investment.
Bibliography, etc. Note
Includes bibliographical references and index.
Record Appears in
Variant Title
Interpreting Agreement on Trade-Related Intellectual Property Rights
Portion of Title
Globalisation of intellectual property rights and access to medicines
Table of Contents
Foreword
vii
Acknowledgements
xii
Table of Cases
xvii
Table of Legislation
xxv
Introduction
1
pt. I
Background
1.
Innovation Incentives
9
2.
International IP Cooperation and Developing Country Perspectives
29
3.
Biotech Inventions and Patentable Subject Matter
59
pt. II
TRIPS Agreement
4.
Uruguay Round Negotiations and the Adoption of TRIPS
105
5.
TRIPS Agreement de Lege Lata: the Outline
148
6.
Various Methods of Interpretation: WTO Agreements and the Vienna Convention on the Law of Treaties
190
7.
TRIPS Provisions as Interpreted by the WTO Dispute Settlement Organs
209
pt. III
Access to Medicines
8.
AIDS Epidemic and TRIPS
261
9.
Doha Declaration and Beyond
304
pt. IV
IP and Industrial Policies
10.
Emerging Economies' IP and Industrial Policies
345
11.
Pharmaceutical Industries, R&D and Public Health in Emerging Economies
388
pt. V
TRIPS Flexibilities and National Implementation
12.
TRIPS Flexibilities and National Implementation (1) Patentable Subject Matter and Patentability Requirements
419
13.
TRIPS Flexibilities and National Implementation (2) Protection of Test Data Submitted to Regulatory Authorities
469
14.
`TRIPS Plus' Provisions in US Free Trade Agreements
480
pt. VI
Interpreting TRIPS for Innovation
15.
Recasting the Debate on Intellectual Property Rights
513
Index
521